Displaying 1 to 1 of 1 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
ACT Genomics Co Ltd Provider of cancer molecular information solutions. |
Taiwan | 6 May 2016 | Series B Follow-on investment. Round participant. Active |